GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Net Income Including Noncontrolling Interests

Tci Gene (ROCO:6879) Net Income Including Noncontrolling Interests : NT$17.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Tci Gene's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2023 was NT$4.8 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was NT$17.0 Mil.

Tci Gene Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Tci Gene's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Net Income Including Noncontrolling Interests Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Income Including Noncontrolling Interests
56.50 35.82 92.14 74.34 16.95

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only 65.41 67.57 6.77 12.17 4.78

Tci Gene Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$17.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tci Gene Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Tci Gene's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
ROCO:6580 ROCO:6564 ROCO:6846 TPE:3164 ROCO:4724 ROCO:6892 TPE:4133 ROCO:4171 TPE:1733 ROCO:7427 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN
Website
https://www.genext.me
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines